EPITOPE SUMMARY | |
---|---|
alpha-D-Galp-(1->3)-beta-D-Galp-(1->4)-D-GlcpNAc-yl group (epitope ID ) has this structure: studied as part of alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer, glycolipid, Envelope glycoprotein (UniProt:P03385) from Murine leukemia virus (murine leukemia virus MLV), Mucin TcMUCII, putative (UniProt:Q4E5Y0) from Trypanosoma cruzi, alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-Glc and Laminin subunit alpha-1 (UniProt:P19137) from Mus musculus (mouse). The epitope has these synonyms: alpha-D-galactopyranosyl-(1->3) beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-D-glucopyranosyl, alpha-D-galactopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-D-glucopyranosyl, alpha-D-Gal(1->3)-beta-D-Gal(1->4)-D-GlcNAc-yl group, alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-D-GlcNHAc-R, alpha-D-galactopyranosyl-(1->3) beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-D-glucopyranosyl group, alpha-D-Galactosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-N-acetylglucosaminyl-R, alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-D-glucosaminyl group, alpha-D-Galactosyl-1,3-beta-D-galactosyl-1,4-N-acetyl-D-glucosaminyl-R, alpha-D-galactosyl-beta-1,3-D-galactosyl-beta-1,4-N-acetyl-D-glucosaminyl group, alpha-D-Galp-(1->3)-beta-D-Galp-(1->4)-D-Glcp-NAc-yl group, alpha-D-Galp-(1->3)-beta-D-Galp-(1->4)-D-GlcpNHAc-R, alpha-gal, alpha-Gal trisaccharide, alpha-Gal trisaccharide epitope, alpha-Gal3, alpha-galactosyl epitope, Gal(alpha1->3)-Gal(beta1->4)-GlcNAc-R, Galalpha1-3Galbeta1-4GlcNAc-, Galalpha1-3LacNAc-. This epitope has been studied for immune reactivity in publication(s), tested in T cell assays and B cell assays. |
CURATED EXPERIMENTAL DATA | |
---|---|
B Cell Assay(s) | |
Assay Type | Positive / All |
qualitative binding | / |
agglutination | / |
tolerance | / |
neutralization | / |
complement-dependent cytotoxicity | / |
decreased disease | / |
antibody-dependent cellular cytotoxicity | / |
dissociation constant KD | / |
opsonization | / |
decreased disease after adoptive transfer | / |
disease exacerbation | / |
tolerance after adoptive transfer | / |
antibody activity inhibition | / |
histamine release | / |
off rate | / |
on rate | / |
T Cell Assay(s) | |
Assay Type | Positive / All |
proliferation | / |